Evaluation of prediction score of contrast-induced nephropathy in inpatients undergone to digital or CT angiography

Main Article Content

Seleno Glauber de Jesus-Silva
https://orcid.org/0000-0002-2205-1090
Ana Elisa Chaves
https://orcid.org/0000-0003-0567-8112
Caio Augusto Alves Maciel
https://orcid.org/0000-0001-8807-831X
Edson Eziel Ferreira Scotini
Pablo Girardelli Mendonça Mesquita
Melissa Andreia de Moraes Silva
https://orcid.org/0000-0001-8773-3095
Rodolfo Souza Cardoso
https://orcid.org/0000-0003-0212-240X

Abstract

Objectives: To assess the incidence of contrast-induced nephropathy (CIN) and determine the Mehran Score's (MS) ability to predict CIN in patients undergoing digital angiography or computed tomography angiography. Methods: 252 medical records of inpatients who underwent DA or CTA over 28 months in a quaternary hospital were reviewed. CIN was defined as serum creatinine> 0.5 mg / dL or > 25% increase in baseline creatinine, 48 h after administration of iodinated contrast. The ROC curve and the area under the curve (AUC) were used as a score test. Results: The majority (159; 63.1%) were male, and the average age was 60.4 years. Anemia, diabetes mellitus, and age > 75 years were the most prevalent factors. The incidence of CIN was 17.8% (n = 45). There was a decrease in the mean values ​​of creatinine pre and post among patients who did not suffer CIN (1.38 ± 1.22 vs 1.19 ± 0.89; t = 3.433; p = 0.0007), while among patients who suffering CIN, the mean increase was 1.03 mg / dL (1.43 ± 1.48 vs 2.46 ± 2.35 mg / dL; t = 5.44; p = 0.117). The ROC curve analysis identified a low correlation between MS and the occurrence of CIN (AUC = 0.506). Conclusion: The incidence of CIN in hospitalized patients undergoing angiography or computed tomography angiography was high. The EM did not allow the prediction of NIC.




Article Details

How to Cite
1.
Jesus-Silva SG de, Chaves AE, Maciel CAA, Scotini EEF, Mesquita PGM, de Moraes Silva MA, et al. Evaluation of prediction score of contrast-induced nephropathy in inpatients undergone to digital or CT angiography. HSJ [Internet]. 2020 Sep. 11 [cited 2024 Nov. 4];10(3):78-84. Available from: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/974
Section
ORIGINAL ARTICLE
Author Biographies

Seleno Glauber de Jesus-Silva, Itajuba Clinics Hospital

Master of Science. Vascular Surgeon and Interventional Radiologist of Itajuba Clinics Hospital (HCI). General Coordinator of Medical Residency of the HCI.

Ana Elisa Chaves, Faculty of Medicine of Itajubá

Sixth year medical student at the Faculty of Medicine of Itajuba.

Caio Augusto Alves Maciel, Faculty of Medicine of Itajubá

Sixth year medical student at the Faculty of Medicine of Itajubá.

Edson Eziel Ferreira Scotini, Itajuba Clinics Hospital

Former resident physician of the General Surgery Medical Residency Program at Itajuba Clinics Hospital.

Pablo Girardelli Mendonça Mesquita, Itajuba Clinics Hospital/Faculty of Medicine of Itajuba

Master of Science. Professor at the Faculty of Medicine of Itajuba. Nephrologist at the Itajuba Clinics Hospital.

Melissa Andreia de Moraes Silva, Itajuba Clinics Hospital / Faculty of Medicine of Itajubá

Master in Sciences and PhD from the Federal University of São Paulo. Professor at the Faculty of Medicine of Itajubá. Vascular Surgeon and Vascular Ultrasonographer at Itajuba Clinics Hospital.

Rodolfo Souza Cardoso, Itajuba Clinics Hospital

Vascular Surgeon and Interventional Radiologist at Hospital de Clínicas de Itajubá. Member of the Brazilian College of Surgeons. Executive Director of Hospital de Clínicas de Itajubá.

References

Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2004;44(7):1393-99. https://doi.org10.1016/j.jacc.2004.06.068

Vijay SK, Tiwari BC, Singh AK. Contrast induced nephropathy: pathophysiology and prevention. Heart India. 2013;1(2);39-45. https://doi.org/10.4103/2321-449x.118580

Maccariello E. Nefropatia Induzida por contraste. J Bras Nefrol. 2016;38(4):388-9. https://doi.org/10.5935/0101-2800.20160062 PMid:28001182

Kuo C, Chou R, Lu Y, et al. Increased circulating galectin-1 levels are associated with the progression of kidney function decline in patients undergoing coronary angiography. Sci Rep.2020;10:1435. https://doi.org/10.1038/s41598-020-58132-1 PMid:31996694 PMCid:PMC6989666

Santos RO, Malvar B, Silva R, et al. Nefropatia de contraste. Acta Med Port [Internet]. 2011 [cited 2020 Sep 9];24: 809-20. Avaiable from: actamedicaportuguesa.com/revista/index.php/amp/article/viewFile/504/212

Kramer CK, Leitão CB, Canani LH, Gross JL, Silveiro SP. Contrast-induced nephropathy: prevention strategies. Clin Biomed Res [Internet]. 2008 [cited 2020 Sep 9];28(1): 33-6. Avaiable from: https://seer.ufrgs.br/hcpa/article/view/3177

Pyka Ł, Hawranek M, Wilczek K, Piegza J, Szkodzinski J, Lekston A, et al. Imaging-guided percutaneous coronary intervention with ultra-low contrast angiographic control for patients at extreme risk of contrast induced nephropathy. Cardiol J. 2019;26(6):796-8. https://doi.org/10.5603/CJ.2019.0117 PMid:31970738

Moura ELB, Amorim FF, Huang W, Maia MO. Lesão renal aguda induzida por contraste: importância dos critérios diagnósticos para estabelecer a prevalência e o prognóstico na unidade de terapia intensiva. Rev Bras Ter Intensiva. 2017;29(3):303-9. https://doi.org/10.5935/0103-507X.20170041 PMid:28876404 PMCid:PMC5632972

Reddan D, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings? J Nephrol. 2009;22(3):333-51. PMID: 19557710

Santos PR, Neto JDC, Arcanjo FPN, Carneiro RCCP, Amaral CL. Contrast-induced nephropathy after primary angioplasty for acute myocardial infarction. J Bras Nefrol. 2015;37(4):439-45. https://doi.org/10.5935/0101-2800.20150070

Machado MC, Castagna MT, Reis G, Motta MS, Oliveira JV, Oliveira AL, Campos Neto MS. Nefropatia por radiocontraste: tendências atuais. Rev Bras Cardiol Invas. 2003;11(4):27-30.

Gouveia R, Bravo P, Santos C, Ramos A. Contrast-induced acute kidney injury - a review focusing on prophylactic strategies. Angiol Cir Vasc [Internet]. 2015 [cited 2020 Sep 9];11(2):68-78. https://doi.org/10.1016/j.ancv.2015.01.009

Evola S, Lunetta M, Macaione F, Fonte G, Milana G, Corrado E, Bonura F, Novo G, Hoffmann E, Novo S. Risk factors for contrast induced nephropathy: a study among Italian patients. Indian Heart J. 2012;64(5):484-91. https://doi.org/10.1016/j.ihj.2012.07.007 PMid:23102387 PMCid:PMC3860804

Raingruber B, Kirkland-Walsh H, Chahon N, Kellermann M. Using the Mehran risk scoring tool to predict risk for contrast medium-induced nephropathy in patients undergoing percutaneous angiography. Crit Care Nurse. 2011;31(1):e17-e22. https://doi.org/10.4037/ccn2011746 PMid:21285460

Sgura FA, Bertelli L, Monopoli D, et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2010;3(5):491-498. https://doi.org/10.1161/CIRCINTERVENTIONS.110.955310 PMid:20923986

Antunes LF, Baptista A, Moreira J, Anacleto G, Gonçalves Ó, Matos A. Insuficiência renal induzida por contraste: estudo prospectivo. Angiol Cir Vasc [Internet]. 2013 [cited 2020 Sep 10];9(2):59-63. https://doi.org/10.1016/S1646-706X(13)70017-X

Ortega LM, Harmouch I, Nayer A. Contrast-induced nephropathy: pathogenesis and new therapeutic options for prevention. Am J Ther. 2015;22(6):469-476. https://doi.org/10.1097/MJT.0000000000000163 PMid:25470612

Wi J, Ko YG, Shin DH, et al. Prediction of Contrast-Induced Nephropathy With Persistent Renal Dysfunction and Adverse Long-term Outcomes in Patients With Acute Myocardial Infarction Using the Mehran Risk Score. Clin Cardiol. 2013;36(1):46-53. https://doi.org/10.1002/clc.22060 PMid:23027701 PMCid:PMC6649613

Funaki B. Contrast-induced nephropathy: what we know, what we think we know, and what we don't know. Semin Intervent Radiol. 2005;22(2):108-13. https://doi.org/10.1055/s-2005-871865 PMid:21326680 PMCid:PMC3036263

Zungur M, Gul I, Tastan A, Damar E, Tavli T. Predictive value of the Mehran Score for contrast-induced nephropathy after transcatheter aortic valve implantation in patients with aortic stenosis. Cardiorenal Med. 2016;6(4):279-288. https://doi.org/10.1159/000443936 PMid:27648009 PMCid:PMC5020403

Sadat U, Walsh SR, Norden AG, Gillard JH, Boyle JR. Does oral N-acetylcysteine reduce contrast-induced renal injury in patients with peripheral arterial disease undergoing peripheral angiography? A randomized-controlled study. Angiology. 2011;62(3):225-230. https://doi.org/10.1177/0003319710377078 PMid:20682612

Abellás-Sequeiros RA, Raposeiras-Roubín S, Abu-Assi E, et al. Mehran contrast nephropathy risk score: Is it still useful 10 years later?. J Cardiol. 2016;67(3):262-267. https://doi.org/10.1016/j.jjcc.2015.05.007 PMid:26169247

Ni Z, Liang Y, Xie N, et al. Simple pre-procedure risk stratification tool for contrast-induced nephropathy [published correction appears in J Thorac Dis. 2019;11(7):E105]. J Thorac Dis. 2019;11(4):1597-1610. https://doi.org/10.21037/jtd.2019.04.69 PMid:31179104 PMCid:PMC6531701

Most read articles by the same author(s)

1 2 3 4 > >>